Abbott Rapid Dx North America LLC, Orlando, Florida, was awarded a $1,027,500,000 modification (P00003) to contract W58P05-22-C-0008 for COVID-19 rapid antigen test kits. Work will be performed in Orlando, Florida, with an estimated completion date of June 26, 2022. American Rescue Plan Act funds in the amount of $1,027,500,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity. (Awarded March 23, 2022)